Fresenius SE Inventory Turnover Ratio 2016-2023 | FSNUY
Current and historical inventory turnover ratio for Fresenius SE (FSNUY) from 2016 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Fresenius SE inventory turnover ratio for the three months ending September 30, 2023 was 1.59.
| Fresenius SE Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $17.269B | $24.011B |
| Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $15.262B | 15.77 |
| DaVita (DVA) | United States | $11.791B | 14.65 |
| Chemed (CHE) | United States | $8.503B | 26.36 |
| Encompass Health (EHC) | United States | $8.333B | 21.45 |
| Elanco Animal Health (ELAN) | United States | $6.685B | 15.20 |
| Option Care Health (OPCH) | United States | $5.181B | 19.61 |
| RadNet (RDNT) | United States | $3.783B | 102.40 |
| Amedisys (AMED) | United States | $3.009B | 21.31 |
| LifeStance Health (LFST) | United States | $2.546B | 0.00 |
| Astrana Health (ASTH) | United States | $2.099B | 26.20 |
| Addus HomeCare (ADUS) | United States | $1.608B | 24.43 |
| U.S Physical Therapy (USPH) | United States | $1.585B | 41.09 |
| Pennant (PNTG) | United States | $0.642B | 37.54 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.448B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.343B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.026B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.011B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |